Venmax Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 February 2025.Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 January 2025.Powered by Capital Market - Live News

Net Loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.30 crore in the quarter ended September 2024 as against net loss of Rs 0.03 crore during the previous quarter ended September 2023. Sales reported to Rs 0.17 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.170 0 OPM %-176.470 - PBDT-0.30-0.03 -900 PBT-0.30-0.03 -900 NP-0.30-0.03 -900 Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live News